A review of incidentally detected pancreatic cystic lesions highlights key steps to classify mucinous vs non-mucinous cysts on CT/MRI, a distinction that can reduce management delays because mucinous lesions carry malignant transformation risk. The paper emphasizes that no single imaging feature is definitive; instead, routine practice should use a reproducible, pattern-based assessment integrating duct communication, morphology, wall features, internal architecture, calcifications, multiplicity, and clinical context.

Why It Matters To Your Practice

• Incidental pancreatic cysts are increasingly common on high-resolution CT and MRI.

• The main clinical task is separating mucinous from non-mucinous lesions, since mucinous cysts have different surveillance, referral, and treatment pathways.

• This review supports a structured imaging approach that can help clinicians recognize when a cyst may represent a malignant neoplasm precursor versus a lower-risk lesion.

Clinical Benefits

• Focus on reproducible CT/MRI features: communication with the main pancreatic duct, lesion shape, wall thickness, enhancement, septations or nodules, calcification pattern, multiplicity, and associated ductal/parenchymal changes.

• Encourages combining imaging findings with patient demographics, lesion distribution, symptoms, and interval change over time.

• Reinforces a pattern-based read rather than relying on any single feature in isolation.

Managing Risks

• Imaging overlap is common, especially with atypical lesion location or presentation.

• CT/MRI may not definitively classify every cyst; diagnostic uncertainty should be stated clearly.

• When features are indeterminate or concerning, multidisciplinary review remains the safest next step.

• AI tools are promising but not yet supported for routine clinical use.

The Bottom Line

• For NPs and PAs, the key step is to use a systematic CT/MRI checklist and avoid overcalling a cyst based on one feature alone.

• Escalate care when mucinous features, duct involvement, worrisome morphology, or uncertainty are present, as expert interpretation still anchors management.